---
title: "Sionna’s SION-719 showed no benefit vs. Trikafta in Phase 2 add-on trial"
id: "stat-news-0-stat-sionna-s-experimental-cystic-fibrosis-pill-falls-flat-in-mid-stage-trial"
canonical_url: "https://medichelpline.com/clinical-feed/stat-news-0-stat-sionna-s-experimental-cystic-fibrosis-pill-falls-flat-in-mid-stage-trial"
content_type: "clinical_feed_article"
specialty: "Pharmacology"
source_name: "STAT News"
source_url: "https://www.statnews.com/2026/08/10/sionna-cystic-fibrosis-trial-failures-sion719-vertex-trikaft/?utm_campaign=rss"
published_at: "2026-08-10T12:03:17.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Sionna’s SION-719 showed no benefit vs. Trikafta in Phase 2 add-on trial
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/stat-news-0-stat-sionna-s-experimental-cystic-fibrosis-pill-falls-flat-in-mid-stage-trial
- **Specialty:** [Pharmacology](https://medichelpline.com/clinical-feed/pharmacology.md)
- **Primary Source:** STAT News
- **Source URL:** [Original Journal Publication](https://www.statnews.com/2026/08/10/sionna-cystic-fibrosis-trial-failures-sion719-vertex-trikaft/?utm_campaign=rss)
- **Published At:** 2026-08-10T12:03:17.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- Sionna Therapeutics announced that its experimental oral drug **SION-719** did not demonstrate benefit when added to Vertex Pharmaceuticals’ **Trikafta** in a Phase 2 cystic fibrosis (CF) trial. - The company said it will stop developing SION-719 as an **add-on therapy** for people with **cystic fibrosis** based on the trial results. - Sionna indicated it will “take actions to preserve capital while evaluating next steps,” and hinted at potential workforce reductions. - Following the announcement, Sionna’s stock dropped about **90%** in pre-market trading on the morning the news was released. - The publicly available report did not provide trial design details such as enrollment numbers, dosing regimens, endpoints measured, statistical results, safety data, or timelines for the study. - The source did not report whether Sionna will pursue other development pathways for SION-719 (for CF or other indications) beyond the decision to stop the add-on program. - The article emphasized that SION-719 offered no added benefit over **Trikafta** alone, implying the drug failed to meet its objectives in the mid-stage study.
## Clinical Analysis & Structured Key Points
[Skip to Main Content](https://www.statnews.com/2026/08/10/sionna-cystic-fibrosis-trial-failures-sion719-vertex-trikaft/?utm_campaign=rss#wrapper) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo-white.svg) ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) ](https://www.statnews.com/) * [Manage alerts for this article](https://www.statnews.com/my-account/edit/#emails) * Email this article * [Share this article](https://www.statnews.com/2026/08/10/sionna-cystic-fibrosis-trial-failures-sion719-vertex-trikaft/?utm_campaign=rss) [Cancer](https://www.statnews.com/topic/cancer/) [oncology](https://www.statnews.com/topic/oncology/) [research](https://www.statnews.com/topic/research/) * [Newsletters](https://www.statnews.com/signup/) * [Log In](https://www.statnews.com/login/) * [My Account](https://www.statnews.com/my-account/) * [Subscribe Now](https://www.statnews.com/stat-plus/) My Account * [Settings Complete your personal information for a more tailored experience ](https://www.statnews.com/my-account/) * [Billing](https://www.statnews.com/my-account/billing/) * [Log In](https://www.statnews.com/login/) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) Reporting from the frontiers of health and medicine ](https://www.statnews.com/) * [Newsletters](https://www.statnews.com/signup/) * [Log In](https://www.statnews.com/login/) * [My Account](https://www.statnews.com/my-account/) * [Subscribe Now](https://www.statnews.com/stat-plus/) * [Biotech](https://www.statnews.com/category/biotech/) * [Pharma](https://www.statnews.com/category/pharma/) * [Public Health](https://www.statnews.com/category/health/) * [Health Tech](https://www.statnews.com/category/health-tech/) * [Policy](https://www.statnews.com/category/politics/) * [Science](https://www.statnews.com/category/in-the-lab/) * [First Opinion](https://www.statnews.com/category/first-opinion/) * [STAT+](https://www.statnews.com/topic/stat-plus/) * [STAT Events](https://www.statnews.com/events/) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) ](https://www.statnews.com/) Search * [Log In](https://www.statnews.com/login/) * [Subscribe Now](https://www.statnews.com/stat-plus/) * [My Account](https://www.statnews.com/my-account/) [Home](https://www.statnews.com/) News * [Latest](https://www.statnews.com/latest/) * [Series & Investigations](https://www.statnews.com/stat-series-and-investigations-award-winning-journalism/) * Business * [Biotech](https://www.statnews.com/category/biotech/) * [Pharma](https://www.statnews.com/category/pharma/) * [Health Tech](https://www.statnews.com/category/health-tech/) * [Health Insurance](https://www.statnews.com/category/insurance/) * [Hospitals](https://www.statnews.com/category/hospitals/) * [Medical Devices](https://www.statnews.com/topic/medical-devices/) * Washington * [Policy](https://www.statnews.com/category/politics/) * [FDA](https://www.statnews.com/topic/fda/) * [NIH](https://www.statnews.com/topic/nih/) * Science * [CRISPR](https://www.statnews.com/topic/crispr/) * [Gene Therapy](https://www.statnews.com/topic/gene-therapy/) * [Neuroscience](https://www.statnews.com/topic/neuroscience/) * Public Health * [Addiction](https://www.statnews.com/topic/addiction/) * [Covid-19](https://www.statnews.com/topic/coronavirus/) * [Abortion](https://www.statnews.com/topic/abortion/) * [Health Disparities](https://www.statnews.com/topic/health-disparities/) * [Infectious Disease](https://www.statnews.com/topic/infectious-disease/) * [Mental Health](https://www.statnews.com/topic/mental-health/) * Disease * [Cancer](https://www.statnews.com/topic/cancer/) * [Cardiovascular Disease](https://www.statnews.com/topic/cardiovascular-disease/) * [Chronic Disease](https://www.statnews.com/topic/chronic-disease/) * [Diabetes](https://www.statnews.com/topic/diabetes/) * [Alzheimer's](https://www.statnews.com/topic/alzheimers/) * [Obesity](https://www.statnews.com/topic/obesity/) * Features * [Health Care Costs](https://www.statnews.com/health-insurance-costs-out-of-pocket-out-of-reach-series/) * [The Deadliest Drug](https://www.statnews.com/alcohol-epidemic-hiding-plain-sight-deadliest-drug-series/) * [Science, Shattered](https://www.statnews.com/american-science-shattered/) [Newsletters](https://www.statnews.com/signup/) [Opinion](https://www.statnews.com/category/first-opinion/) Columns * [Adam Feuerstein](https://www.statnews.com/category/adams-take/) * [Matthew Herper](https://www.statnews.com/category/matts-take/) * [Ed Silverman](https://www.statnews.com/category/pharmalot-view/) [Reports](https://reports.statnews.com/) [E-books](https://www.statnews.com/ebooks/) [Podcasts](https://www.statnews.com/podcasts/) [Tools & Trackers](https://www.statnews.com/trackers/) * [CRISPR Tracker](https://www.statnews.com/feature/crispr/tracker/) * [Breakthrough Device Tracker](https://www.statnews.com/feature/stat-plus/breakthrough-device-designation-fda-tracker/) * [Generative AI Tracker](https://www.statnews.com/feature/stat-plus/generative-ai-health-hospitals-tracker/) * [Obesity Drug Tracker](https://www.statnews.com/2023/09/12/new-weight-loss-drug-tracker-novo-nordisk-eli-lilly/) [Events](https://www.statnews.com/events/) * [Upcoming Events](https://www.statnews.com/events#upcoming-events) * [Summits](https://www.statnews.com/stat-summits/) [Community](https://www.statnews.com/community/) * [STAT Wunderkinds 2026](https://www.statnews.com/wunderkinds-nominate/) [Video](https://youtube.com/@Statnews) [Advertise](https://www.statnews.com/advertise/) * [STAT Brand Studio](https://sbs.statnews.com/) What's the word? Test your knowledge with our new weekday mini crossword [ Start solving ](https://www.statnews.com/stat-mini-crossword/) [STAT Plus](https://www.statnews.com/stat-plus/)[Biotech](https://www.statnews.com/category/biotech/) # Sionna’s experimental cystic fibrosis pill falls flat in mid-stage trial ## Experimental pill proved no better than Vertex’s blockbuster Trikafta alone * [Manage alerts for this article](https://www.statnews.com/my-account/edit/#emails) * Email this article * [Share this article](https://www.statnews.com/2026/08/10/sionna-cystic-fibrosis-trial-failures-sion719-vertex-trikaft/?utm_campaign=rss) ![purple lungs ct](https://www.statnews.com/wp-content/uploads/2020/04/AdobeStock_269344651-645x645.jpeg) Adobe ![](https://www.statnews.com/wp-content/uploads/2022/05/jason-mast-avatar-round-80x80.png) By [Jason Mast](https://www.statnews.com/staff/jason-mast/) Aug. 10, 2026 General Assignment Reporter ![](https://www.statnews.com/wp-content/uploads/2022/05/jason-mast-avatar-round-80x80.png) [Jason Mast](https://www.statnews.com/staff/jason-mast/) 1. [](https://x.com/JasonMMast "X") jason.mast@statnews.com Jason is a general assignment reporter, with particular focus on genetic medicine and rare disease. Confidential tips can be sent on Signal at JasonMast.77. Sionna Therapeutics said Monday that its experimental pill for cystic fibrosis did not show any benefit when added onto Vertex Pharmaceuticals’ Trikafta in a Phase 2 trial. The company will no longer try to advance the drug, called SION-719, as an add-on therapy for CF patients. And it hinted at potential layoffs, saying it will “take actions to preserve capital while evaluating next steps.” Advertisement Sionna’s stock fell 90% in pre-market trading Monday morning. STAT+ Exclusive Story Already have an account? [Log in](https://www.statnews.com/login/) ![STAT+](https://www.statnews.com/wp-content/themes/stat/images/stat-plus-breaker-bg.png) [ ![STAT+](https://www.statnews.com/wp-content/themes/stat/images/stat-plus-logo-white.svg) ](https://www.statnews.com/stat-plus/) ## This article is exclusive to STAT+ subscribers ### Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+. Already have an account? [Log in](https://www.statnews.com/login/) Individual plans Group plans Monthly $39 Totals $468 per year [$39/month](https://www.statnews.com/stat-plus/subscribe/?plan=stat-plus-monthly-39-0) [Get Started](https://www.statnews.com/stat-plus/subscribe/?plan=stat-plus-monthly-39-0) Totals $468 per year Starter $30 for 3 months, then $399/year [$30 for 3 months](https://www.statnews.com/stat-plus/subscribe/?plan=3mo30_yearly_pw) [Get Started](https://www.statnews.com/stat-plus/subscribe/?plan=3mo30_yearly_pw) Then $399/year Annual $399 Save 15% [$399/year](https://www.statnews.com/stat-plus/subscribe/?plan=stat-plus-annually-399-0) [Get Started](https://www.statnews.com/stat-plus/subscribe/?plan=stat-plus-annually-399-0) Save 15% 11+ Users Custom Savings start at 25%! [Request A Quote](https://www.statnews.com/stat-plus/group-subscriptions/) [Request A Quote](https://www.statnews.com/stat-plus/group-subscriptions/) Savings start at 25%! 2-10 Users $300 Annually per user [$300/year](https://www.statnews.com/stat-plus/subscribe/?plan=stat_plus_groups_self_serve_0) [Get Started](https://www.statnews.com/stat-plus/subscribe/?plan=stat_plus_groups_self_serve_0) $300 Annually per user [View All Plans](https://www.statnews.com/stat-plus/) [![STAT+](https://www.statnews.com/wp-content/themes/stat/images/stat-plus-logo.svg)](https://www.statnews.com/stat-plus/) To read the rest of this story subscribe to STAT+. [Subscribe](https://www.statnews.com/stat-plus/) [Log In](https://www.statnews.com/login/) [biotechnology](https://www.statnews.com/topic/biotechnology/), [drug development](https://www.statnews.com/topic/drug-development/), [STAT+](https://www.statnews.com/topic/stat-plus/) [Submit a correction request](https://www.statnews.com/contact/?how_can_we_help_=Editorial%20Correction%20Request)[Reprints](https://www.parsintl.com/publications/stat/) 1. ![](https://www.statnews.com/wp-content/uploads/2022/05/jason-mast-avatar-round-80x80.png) [Jason Mast](https://www.statnews.com/staff/jason-mast/) 1. [](https://x.com/JasonMMast "X") 2. General Assignment Reporter 1. [](https://x.com/JasonMMast "X") 2. Jason is a general assignment reporter, with particular focus on genetic medicine and rare disease. Confidential tips can be sent on Signal at JasonMast.77. ![](https://www.statnews.com/wp-content/themes/stat/images/article-new/envelope-open.svg) ![](https://www.statnews.com/wp-content/uploads/2023/06/Morning-Rounds-Logo-Black-640x295.png) ### Newsletter Understand how science, health policy, and medicine shape the world every day Please enter a valid email address. Sign Up Your data will be processed in accordance with our [Privacy Policy](https://www.statnews.com/privacy/) and [Terms of Service](https://www.statnews.com/terms-conditions/). You may opt out of receiving STAT communications at any time. Advertisement Most Popular 1. ![](https://www.statnews.com/wp-content/uploads/2026/08/AdobeStock_1260243913-80x80.jpeg) [MRI is standard for diagnosing prostate cancer in most western countries. But most U.S. men don’t get them](https://www.statnews.com/2026/08/05/prostate-cancer-screening-biopsy-vs-mri-debate/) 2. ![](https://www.statnews.com/wp-content/uploads/2026/01/heart-1-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Heart failure drug from Tenax Therapeutics fails in pivotal study](https://www.statnews.com/2026/08/10/tenax-heart-failure-drug-trail-failure-levosimendan-ph-hfpef/) 3. ![](https://www.statnews.com/wp-content/uploads/2023/06/AdobeStock_466426746-80x80.jpeg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Silence Therapeutics aims at Takeda with new data in rare blood cancer](https://www.statnews.com/2026/08/10/silence-polycythemia-vera-trial-results-divesiran-takeda-rusfertide/) 4. ![](https://www.statnews.com/wp-content/uploads/2024/12/DSC00011-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [A shortage of two Sanofi medicines for Pompe disease rattles patients](https://www.statnews.com/pharmalot/2026/08/09/sanofi-pompe-disease-drug-shortage-myozyme-nexviazyme/) 5. ![](https://www.statnews.com/wp-content/uploads/2026/08/GettyImages-2269935478-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [China tightens the reins on clinical trials, even as the U.S. looks for ways to replicate its rival’s speed](https://www.statnews.com/2026/08/10/china-biotech-new-scrutiny-investigator-initiated-trials/) #### [ Reports ](https://reports.statnews.com/) [ ![](https://www.statnews.com/wp-content/uploads/2025/08/VCFirms2025_LeftRailUnit-328x426.png) 2025 Edition: Ranking Biotech’s Top Venture Capital Firms ](https://reports.statnews.com/products/biotech-top-venture-capital-firms-2025) Advertisement #### [Events](https://www.statnews.com/events/) [ ![](https://www.statnews.com/wp-content/uploads/2026/06/2026AAIC_Wordpress_CalendarImage-80x80.jpg) AAIC Recap: What’s Next in Alzheimer’s Virtual Jul 16 ](https://www.statnews.com/event/2026-aaic-recap-alzheimers-conference/) [ ![](https://www.statnews.com/wp-content/uploads/2026/07/2026_OfficeHours_VirtualEvent_Wordpress_CalendarImage-1-80x80.jpg) Office Hours with STAT’s Bob Herman Virtual Jul 22 ](https://www.statnews.com/event/out-of-pocket-series-bob-herman-office-hours-ama-july-2026/) [ ![](https://www.statnews.com/wp-content/uploads/2026/07/2026_DD_OfficeHours_VirtualEvent_Wordpress_CalendarImage-80x80.jpg) Office Hours with Isabella Cueto and Lev Facher Virtual Jul 29 ](https://www.statnews.com/event/deadliest-drug-series-office-hours-ama-july-2026/) Most Read in [STAT+](https://www.statnews.com/stat-plus/) 1. ![](https://www.statnews.com/wp-content/uploads/2026/07/AdobeStock_2111261602_Editorial_Use_Only-80x80.jpeg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Eli Lilly to allow more patients to apply for special access to unapproved obesity drug](https://www.statnews.com/2026/08/03/eli-lilly-retatrutide-mystery-patient-doctors-seek-same-access-their-patients/) 2. ![](https://www.statnews.com/wp-content/uploads/2026/08/AdobeStock_1666307366-80x80.jpeg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Once again, child dies in gene-editing trial in China, rekindling debate on transparency and safety](https://www.statnews.com/2026/08/05/china-clinical-trial-fatality-safety-questions-investigator-led-studies/) 3. ![](https://www.statnews.com/wp-content/uploads/2026/08/GettyImages-2245399768-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [NIH plans to block international researchers on visas from accessing key funding avenue ](https://www.statnews.com/2026/08/07/nih-k99-pathways-independence-awards-scientists-on-visas-barred/) 4. ![](https://www.statnews.com/wp-content/uploads/2026/08/C0508954-Tau_protein_clusters_TEM-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Study reveals new role for tau, a top target for Alzheimer’s drug development](https://www.statnews.com/2026/08/06/research-finds-how-tau-targets-cells-structure-alzheimers-drug-development/) 5. ![](https://www.statnews.com/wp-content/uploads/2026/07/MUGSHOT_01-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [A most-wanted fugitive appears to have been secretly working as a biotech executive](https://www.statnews.com/2026/07/20/ronald-fischer-rhode-island-fugitive-richard-graydon-biotech/) #### Recommended ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) Biotech Biotech August 10, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Heart failure drug from Tenax Therapeutics fails in pivotal study ](https://www.statnews.com/2026/08/10/tenax-heart-failure-drug-trail-failure-levosimendan-ph-hfpef/) By [Adam Feuerstein](https://www.statnews.com/staff/adam-feuerstein/) ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) Biotech Biotech August 10, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Silence Therapeutics aims at Takeda with new data in rare blood cancer ](https://www.statnews.com/2026/08/10/silence-polycythemia-vera-trial-results-divesiran-takeda-rusfertide/) By [Jason Mast](https://www.statnews.com/staff/jason-mast/) Advertisement ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) Biotech Biotech August 10, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: The promise of radiopharmaceuticals smacks into safety concerns ](https://www.statnews.com/2026/08/10/radiopharmaceuticals-clinical-trials-progress-setbacks/) By [Allison DeAngelis](https://www.statnews.com/staff/allison-deangelis/) ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) Biotech Biotech August 10, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: China tightens the reins on clinical trials, even as the U.S. looks for ways to replicate its rival’s speed ](https://www.statnews.com/2026/08/10/china-biotech-new-scrutiny-investigator-initiated-trials/) By Brian Yang ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) The Readout The Readout August 7, 2026 ### [ Is the biotech capital of the world moving? ](https://www.statnews.com/2026/08/07/biotech-news-boston-kendall-square-losing-ground-in-sf/) By [Meghana Keshavan](https://www.statnews.com/staff/meghana-keshavan/) #### Subscriber Picks 1. ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Once again, child dies in gene-editing trial in China, rekindling debate on transparency and safety ](https://www.statnews.com/2026/08/05/china-clinical-trial-fatality-safety-questions-investigator-led-studies/) By [Jason Mast](https://www.statnews.com/staff/jason-mast/) and Brian Yang 2. ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Biotech's next big bet: A Tenax study of a heart failure treatment ](https://www.statnews.com/2026/08/06/tenax-study-heart-failure-preview/) By [Adam Feuerstein](https://www.statnews.com/staff/adam-feuerstein/) 3. ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Startup promising to scale custom CRISPR therapies abruptly scraps plans ](https://www.statnews.com/2026/08/04/aurora-therapeutics-ends-program-baby-kj-treatments-beam-therapeutics-jennifer-doudna/) By [Jason Mast](https://www.statnews.com/staff/jason-mast/) and [Allison DeAngelis](https://www.statnews.com/staff/allison-deangelis/) 4. ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Study reveals new role for tau, a top target for Alzheimer’s drug development ](https://www.statnews.com/2026/08/06/research-finds-how-tau-targets-cells-structure-alzheimers-drug-development/) By [Jonathan Wosen](https://www.statnews.com/staff/jonathan-wosen/) 5. ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: The latest orphan drug exemptions may not be warranted, analysis finds ](https://www.statnews.com/pharmalot/2026/08/04/latest-orphan-drug-exemptions-may-not-be-warranted-analysis-finds/) By [Ed Silverman](https://www.statnews.com/staff/ed-silverman/) Share options * [ X ](https://twitter.com/intent/tweet?url=https://www.statnews.com/2026/08/10/sionna-cystic-fibrosis-trial-failures-sion
## Related Clinical Research

- [Neurocrine Biosciences: weighing benefit and risk for a rare-disease drug](https://medichelpline.com/clinical-feed/stat-news-2-stat-neurocrine-biosciences-and-the-delicate-balance-of-benefit-and-risk.md)
- [California’s CalRx insulin rollout is slow to reach patients despite Newsom push](https://medichelpline.com/clinical-feed/stat-news-5-stat-newsom-promotes-affordable-insulin-but-california-s-generic-label-is-off.md)
- [Cardiac-targeted delivery strategies for advanced therapies in heart disease](https://medichelpline.com/clinical-feed/pubmed-42284133.md) (DOI: 10.1093/eurheartj/ehag432)
- [Which Exercises Best Target Blood Pressure, Blood Sugar, and Cholesterol in Metabolic Syndrome?](https://medichelpline.com/clinical-feed/medical-news-today-0-how-do-different-exercises-target-blood-pressure-blood-sugar-and-cholesterol.md)
- [Planetary Health Diet Linked to Lower Cardiovascular Risk in Postmenopausal Women](https://medichelpline.com/clinical-feed/medical-news-today-0-plant-based-planetary-health-diet-could-help-protect-heart-health.md)

## Navigation
- [← Back to Pharmacology Feed](https://medichelpline.com/clinical-feed/pharmacology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.